26.05
Schlusskurs vom Vortag:
$26.83
Offen:
$26.65
24-Stunden-Volumen:
49,167
Relative Volume:
0.16
Marktkapitalisierung:
$170.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-74.14M
KGV:
-2.2871
EPS:
-11.39
Netto-Cashflow:
$-65.70M
1W Leistung:
-0.99%
1M Leistung:
+6.37%
6M Leistung:
+9.22%
1J Leistung:
+151.69%
Instil Bio Inc Stock (TIL) Company Profile
Firmenname
Instil Bio Inc
Sektor
Branche
Telefon
(972) 499-3350
Adresse
3963 MAPLE AVENUE, DALLAS
Vergleichen Sie TIL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TIL
Instil Bio Inc
|
26.01 | 185.97M | 0 | -74.14M | -65.70M | -11.39 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
393.94 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
434.61 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
644.62 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
304.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-07 | Hochstufung | Jefferies | Hold → Buy |
2024-11-04 | Eingeleitet | JMP Securities | Mkt Perform |
2024-04-12 | Herabstufung | Jefferies | Buy → Hold |
2022-11-01 | Herabstufung | Cowen | Outperform → Market Perform |
2022-11-01 | Herabstufung | Truist | Buy → Hold |
2021-08-13 | Eingeleitet | Robert W. Baird | Outperform |
2021-04-13 | Eingeleitet | Cowen | Outperform |
2021-04-13 | Eingeleitet | Morgan Stanley | Equal-Weight |
2021-04-13 | Eingeleitet | Truist | Buy |
Alle ansehen
Instil Bio Inc Aktie (TIL) Neueste Nachrichten
Instil Bio, Inc. SEC 10-Q Report - TradingView
Instil Bio Posts Wider Loss in Q2 - The Motley Fool
Instil Bio Posts Wider Loss in Q2 - Nasdaq
Applying chart zones and confluence areas to Instil Bio Inc.July 2025 News Drivers & Daily Technical Forecast Reports - Newser
Instil Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Instil Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Instil Bio Inc. Testing Reversal Zone on Weekly Chart2025 Performance Recap & Safe Capital Allocation Plans - beatles.ru
Instil Bio Advances Lung Cancer Treatment Pipeline as FDA Clears Key Drug Trial - Stock Titan
Best data tools to analyze Instil Bio Inc. stockJuly 2025 Macro Moves & Real-Time Volume Triggers - Newser
Published on: 2025-08-12 21:39:14 - Newser
Instil Bio Inc.’s volatility index tracking explainedFree Real Market Momentum Signal Generator - Newser
What MACD and RSI say about Instil Bio Inc.Buy Alert Based on RSI and Volume - Newser
Will Instil Bio Inc. stock benefit from interest rate changesFree Real Trader Watchlist of Hot Stocks - Newser
How to manage a losing position in Instil Bio Inc.Free AI-Powered Trade Planning with Indicators - Newser
Chart based analysis of Instil Bio Inc. trendsWeekly Market Direction and Sector Summary - Newser
Sectors Driving Future Growth for Instil Bio Inc. StockFree Weekly Setup With 3x Return Potential - Newser
When is the best time to buy Instil Bio Inc. stockSmart Chart Forecasting with AI Algorithms - Newser
Using RSI to spot recovery in Instil Bio Inc.Market Forecast Summary Over Multi-Year Period - Newser
Instil Bio TIL Q2 2025 Earnings Preview Upside Potential Driven by New Product Launch - AInvest
Why Instil Bio Inc. is moving todayAI Powered Stock Market Trend Forecast - Newser
Is Instil Bio Inc. reversing from oversold territoryValue Investing Summary and Earnings Outlook - Newser
How sentiment analysis helps forecast Instil Bio Inc.Insider Strategy for High Conviction Picks - Newser
Does Instil Bio Inc. stock perform well during market downturnsUnlock exclusive trading strategies for gains - Jammu Links News
Is Instil Bio Inc. stock overvalued or undervaluedUnlock daily market insights for better trades - Jammu Links News
How does Instil Bio Inc. compare to its industry peersInvest like a pro with expert recommendations - Jammu Links News
What is Instil Bio Inc. company’s growth strategyPowerful growth strategies - Jammu Links News
Is Instil Bio Inc. a growth stock or a value stockInvest confidently with data-driven strategies - Jammu Links News
How strong is Instil Bio Inc. company’s balance sheetBuild wealth steadily with proven methods - Jammu Links News
How does Instil Bio Inc. generate profit in a changing economyExceptional gains - Jammu Links News
What are analysts’ price targets for Instil Bio Inc. in the next 12 monthsGet professional advice for portfolio optimization - Jammu Links News
What analysts say about Instil Bio Inc. stockInvest confidently with proven investment plans - Jammu Links News
How many analysts rate Instil Bio Inc. as a “Buy”Unlock exclusive trading strategies for gains - Jammu Links News
What is the risk reward ratio of investing in Instil Bio Inc. stockGet expert alerts on market-moving stocks - Jammu Links News
What are the latest earnings results for Instil Bio Inc.Superior capital gains - Jammu Links News
Should I hold or sell Instil Bio Inc. stock in 2025Unlock powerful portfolio optimization tools - Jammu Links News
What makes Instil Bio Inc. stock price move sharplyInvest in stocks with strong fundamentals - Jammu Links News
How volatile is Instil Bio Inc. stock compared to the marketDiscover dynamic stocks ready to soar - Jammu Links News
Instil Bio Inc. Stock Analysis and ForecastBuild a winning portfolio with smart picks - Jammu Links News
Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer - The Globe and Mail
Finanzdaten der Instil Bio Inc-Aktie (TIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):